Synairgen plc - Data Presented at ESWI Influenza Conference

RNS Number: 8998 U Synairgen plc 08 December 2021. Synairgen Presents In Vitro Potency Data for Interferon Beta Against SARS-CoV-2 Variants and Lung Antiviral Biomarker Data for Inhaled SNG001 at the 8 th ESWI Influenza Conference. Southampton, UK- 8 December 2021: Synairgen plc, the respiratory company developing SNG001, a formulation for inhalation...